Medical Marijuana Use in HIV+ Patients Prospective Cohort Study (MMC-1)
The investigators are interested in understanding personal factors such as medical conditions and mental health, as well as social and economic factors, that influence marijuana (and other substance) use in HIV-positive patients.
Several alternative hypotheses will be evaluated in the proposed project:
- healthier patients may self-select marijuana use;
- marijuana use may be associated with consequences that create barriers to seeking healthcare;
- marijuana use may have medicinal value that reduces the need for such care.
|Study Design:||Observational Model: Cohort
Time Perspective: Prospective
|Official Title:||Behavioral Economic Analysis of Medical Marijuana Use in HIV+ Patients Prospective Cohort Study|
|Study Start Date:||February 2012|
|Estimated Study Completion Date:||December 2014|
|Estimated Primary Completion Date:||December 2014 (Final data collection date for primary outcome measure)|
The study will involve a total of 5 interviews with clinical research staff members, the total involvement will be for about 1 year.
The first interview will establish a baseline of current behaviors and health status; this will take about 3-4 hours. This interview will take place at the Human Pharmacology Laboratory, located 5 miles away from the HIV clinic, at 2761 East Jefferson Ave. The remaining 4 interviews - which will be shorter in length - will be conducted about 3, 6, 9, and 12 months after the baseline interview; each follow-up interview will take about 2 hours. Follow-up visits may be conducted at the HIV clinic or at Jefferson Avenue. The purpose of the 4 remaining interviews is to assess changes in behaviors and health status over time.
We will collect urine samples at each of the 5 interview sessions to assess health and illicit drug use.
|Contact: Lisa Sulkowski, B.S.||(313) firstname.lastname@example.org|
|United States, Michigan|
|Wayne State University (HIV clinic, Jefferson Ave. Research Clinic)||Recruiting|
|Detroit, Michigan, United States, 48202|
|Principal Investigator: Mark Greenwald, PhD|
|Principal Investigator:||Mark Greenwald, PhD||Wayne State University|